Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.1%

17 terminated/withdrawn out of 545 trials

Success Rate

95.8%

+9.2% vs industry average

Late-Stage Pipeline

30%

162 trials in Phase 3/4

Results Transparency

12%

47 of 387 completed trials have results

Key Signals

28 recruiting47 with results14 terminated

Enrollment Performance

Analytics

N/A

229(49.7%)

Phase 3

108(23.4%)

Phase 2

57(12.4%)

Phase 4

54(11.7%)

Phase 1

13(2.8%)

461Total

N/A(229)

Phase 3(108)

Phase 2(57)

Phase 4(54)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (545)

Showing 20 of 545 trials

NCT07551986Not ApplicableRecruiting

Building Cognitive Resilience to Vaccine Misinformation Using AI in Europe

Role: lead

NCT02944682Not ApplicableCompleted

Household Air Pollution and Health: A Multi-country LPG Intervention Trial

Role: collaborator

NCT07488962Not ApplicableCompleted

Building Cognitive Resilience to Vaccine Misinformation Using AI: Evidence From a Randomised Trial

Role: lead

NCT07758985Phase 1Recruiting

Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner in Healthy Participants in Mali.

Role: collaborator

NCT06923592Phase 3Recruiting

Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar

Role: lead

NCT05426577Completed

Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure

Role: collaborator

NCT05003817Phase 3Active Not Recruiting

Controlled Trial of High-risk Coronary Intervention With Percutaneous Left Ventricular Unloading

Role: collaborator

NCT06921213Phase 2Recruiting

Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis

Role: lead

NCT05856357Completed

Perennial Malaria Chemoprevention (PMC) in Côte d'Ivoire

Role: lead

NCT04953130Phase 4Recruiting

Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania

Role: lead

NCT02834637Phase 3Active Not Recruiting

A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls

Role: lead

NCT05889052Completed

Perennial Malaria Chemoprevention (PMC) in Cameroon

Role: lead

NCT07784023Not ApplicableNot Yet Recruiting

Innovative Health Intervention for Ethiopian Migrant Domestic Workers in the Middle East

Role: collaborator

NCT07770048Recruiting

Community-Based Cohort Study of Hidden Malaria Infections, Diagnostic Gaps, & Mosquito Vector Dynamics in Odisha, India

Role: lead

NCT06640075Not ApplicableActive Not Recruiting

Community Co-produced Action for Improved Access to Cervical Cancer Screening in Cameroon

Role: collaborator

NCT06519422Phase 3Recruiting

Tranexamic Acid for Anaemia Trial

Role: lead

NCT06702423Not ApplicableCompleted

AI Chatbot for HPV Vaccine Literacy Among Caregivers in Japan

Role: collaborator

NCT04330599Recruiting

Longitudinal Population-based Observational Study of COVID-19 in the UK Population

Role: collaborator

NCT06347471Phase 4Completed

The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy

Role: collaborator

NCT05890222Not ApplicableCompleted

IMPlementation of Evidence Based Facility and Community Interventions to Reduce the Treatment Gap for depRESSion

Role: collaborator